CBio A/S: Financial statements 2023
CVR: 40216642
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CBio A/S (CVR 40216642) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 5,482,703 and a net result of DKK -621,556 compared with DKK -8,975,691 the year before. Equity in the 2023 report amounted to DKK 5,743,164. The solvency ratio was 25.2%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 5,482,703
- Profit/Loss
- DKK -621,556
- Equity
- DKK 5,743,164
- Total Assets
- DKK 22,749,426
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 5.5 mio. | -622 t. | 5.7 mio. | 9 |
| 2022 | - | -1.1 mio. | -9 mio. | -710 t. | 11 |
| 2021 | - | -1.9 mio. | -8.6 mio. | 8.3 mio. | 11 |
| 2020 | - | -1.8 mio. | -3.9 mio. | 6.8 mio. | 4 |
| 2019 | - | -346 t. | -277 t. | 723 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CBio A/S has published its annual report for 2022. Gross profit came to DKK -1,104,139, and the net result was DKK -8,975,691.
As of June 28, 2023, Lars Rabe Tønnesen has joined the board of directors of CBio A/S.
As of June 28, 2023, Andreea Ioana Kaiser has left the board of directors of CBio A/S.
About CBio A/S
CBio A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cordes Biotech A/S. The management consists of Ulrik Cordes. The board consists of Else Beth Trautner (chair), Christian Henri Leroy, Karin Cecilia Hultén and Lars Rabe Tønnesen. The company's owners include Leroy Capital Fund II Aps, Bildbar ApS and CBio Holding ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 3,671,653 and a net result of DKK -1,802,853 compared with DKK -79,605 the year before. Equity in the 2025 report amounted to DKK 10,475,706.